Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation

The immunosuppressive properties of mesenchymal stromal cells (MSC) have been successfully tested to control clinical severe graft-versus host disease and improve survival. However, clinical studies have not yet provided conclusive evidence of their efficacy largely because of lack of patients’ stra...

Descripción completa

Detalles Bibliográficos
Autores principales: Trento, Cristina, Bernardo, Maria Ester, Nagler, Arnon, Kuçi, Selim, Bornhäuser, Martin, Köhl, Ulrike, Strunk, Dirk, Galleu, Antonio, Sanchez-Guijo, Fermin, Gaipa, Giuseppe, Introna, Martino, Bukauskas, Adomas, Le Blanc, Katarina, Apperley, Jane, Roelofs, Helene, Van Campenhout, Ann, Beguin, Yves, Kuball, Jürgen, Lazzari, Lorenza, Avanzini, Maria Antonietta, Fibbe, Willem, Chabannon, Christian, Bonini, Chiara, Dazzi, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Carden Jennings Publishing 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299357/
https://www.ncbi.nlm.nih.gov/pubmed/30031938
http://dx.doi.org/10.1016/j.bbmt.2018.07.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299357/
https://www.ncbi.nlm.nih.gov/pubmed/30031938
http://dx.doi.org/10.1016/j.bbmt.2018.07.015

Ejemplares similares